Biohaven (BHVN) Net Income towards Common Stockholders (2021 - 2026)

Biohaven has disclosed Net Income towards Common Stockholders across 6 years of filings, most recently posting -$130.5 million for Q1 2026.

• Net Income towards Common Stockholders for Q1 2026 came in at -$130.5 million, up 41.12% year-over-year; the trailing twelve-month figure through Mar 2026 was -$647.7 million (up 27.11% YoY), and the FY2025 annual result was -$738.8 million, up 12.71% from the prior year.
• Net Income towards Common Stockholders came in at -$130.5 million for Q1 2026 at Biohaven, up from -$145.6 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of -$68.9 million in Q3 2022 to a low of -$319.8 million in Q2 2024.
• The 5-year median for Net Income towards Common Stockholders is -$160.3 million (2024), against an average of -$158.5 million.
• Across the five-year window, Net Income towards Common Stockholders slumped 287.59% in 2022 and soared 55.56% in 2023, its largest moves.
• Biohaven's Net Income towards Common Stockholders stood at -$201.1 million in 2022, then advanced by 28.02% to -$144.8 million in 2023, then retreated by 29.07% to -$186.8 million in 2024, then climbed by 22.1% to -$145.6 million in 2025, then climbed by 10.32% to -$130.5 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$130.5 million (Q1 2026), -$145.6 million (Q4 2025), and -$173.4 million (Q3 2025), per Business Quant data.